Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Donald B. Kohn, MD
Researcher Distinguished Professor
University of California, Los Angeles
Box 957357
Los Angeles, California, United States
Dr. Donald Kohn, MD, is a Distinguished Professor of pediatrics and microbiology, immunology and molecular genetics in the life sciences. Dr. Kohn was recruited to the UCLA faculty in 2009 from Childrens Hospital Los Angeles, where he served as an attending physician in the pediatric bone marrow transplant program for more than 20 years.
Dr. Donald Kohn, MD, focuses on the development of new methods to treat genetic diseases of blood cells, such as sickle cell and “bubble baby” disease, as well as using genetic modification of blood stem cells to treat cancer and leukemia. Kohn’s lab studies methods for effective gene transfer and expression and has translated those findings from the lab into clinical trials of gene therapy for congenital immune deficiencies and pediatric AIDS. A trial for sickle cell disease is currently under development.
In addition to being a member of the Broad Stem Cell Research Center, Dr. Kohn directs the Human Gene Medicine Program at UCLA and is a member of UCLA’s Jonsson Comprehensive Cancer Center. He also served as president of the American Society of Gene Therapy from 2003 to 2004, and currently is on the Board of Councilors for the Clinical Immunology Society.
+myBinderRelated Content
-
Carolinas Healthcare System, Levine Children’s HospitalWith the right experts and the right car...
-
Dental Health in Children with Sickle Cell DiseaseWhat is Sickle Cell Disease? Sickle Cel...
-
2019 Annual Sickle Cell Symposium – Sickle Cell: Past Present and FutureDRAFT Agenda 5:00pm Registration, netwo...
-
My medical school lesson was tinged with racism. Did that affect how I treated a sickle cell patient years later?The young woman was curled up in a ball....
-
A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)Limited evidence guides opioid dosing st...
-
Michael U. Callaghan, MDMichael U. Callaghan, MD, is Associate P...
-
DDCF Awards $6 Million for Sickle Cell Disease ResearchThe Doris Duke Charitable Foundation has...
